Episode Summary: 

In this episode of BetterTech on Revolutionizing Drug Approval with AI , host Umair Javed sits down with Umut Eser, Co-founder and CTO of Weave, to explore how AI is transforming the regulatory side of drug approval. With a PhD in applied physics and deep experience across biotech, AI, and healthcare, Umut shares how Weave is simplifying FDA submissions using LLMs, document classification, and agentic workflows. He discusses the challenge of hallucination in regulatory AI, the importance of UX-driven verification, and the balance between automation and human oversight. Whether you’re a health-tech founder or building AI-first products, this episode offers sharp insights into verticalized innovation and product-market fit.

Show Notes:

1. Umut Eser shares insights on building AI-native workflows to streamline regulatory submissions in drug development.
2. The episode explores Weave’s use of LLMs for drafting, verifying, and linking complex scientific documentation.
3. Umut explains how their platform minimizes hallucinations with user-centric design and layered verification.
4. The conversation highlights the value of focusing on narrow, high-impact verticals for AI product success.
5. Umut breaks down Weave’s SaaS model and how they’re scaling adoption across pharma and biotech markets.

This episode is hosted by Umair Javed, Host, BetterTech